| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CHEKCheck-Cap Ltd. | 10.24M | 1.75 | -0.41 | -226.19% | ||||
| NDRAENDRA Life Sciences Inc. | 5.21M | 4.47 | -0.44 | -5.95% | 0.23 | |||
| INBSIntelligent Bio Solutions Inc. | 17.54M | 14.42 | -7.21 | -1.9% | -330.06% | -317.07% | 0.10 |
| Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 188.74K | 1.98M | 0 | 1.26M | 3.11M | 3.05M |
| Revenue Growth % | - | - | - | - | 9.49% | -1% | - | 1.48% | -0.02% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 930.2K | 1.69M | 1.81M |
| COGS % of Revenue | - | - | - | - | - | - | 0.74% | 0.54% | 0.59% |
| Gross Profit | 0 | 0 | 0 | 188.74K | 1.98M | 0 | 326.67K | 1.43M | 1.25M |
| Gross Margin % | - | - | - | 1% | 1% | - | 0.26% | 0.46% | 0.41% |
| Gross Profit Growth % | - | - | - | - | 9.49% | -1% | - | 3.36% | -0.13% |
| Operating Expenses | 173K | 4.6M | 6.73M | 3.05M | 7.55M | 8.34M | 12.92M | 11.71M | 11.89M |
| OpEx % of Revenue | - | - | - | 16.14% | 3.81% | - | 10.28% | 3.76% | 3.9% |
| Selling, General & Admin | 173K | 2.08M | 3.55M | 2.2M | 3.36M | 4.92M | 8.03M | 9.26M | 8.88M |
| SG&A % of Revenue | - | - | - | 11.67% | 1.7% | - | 6.39% | 2.98% | 2.91% |
| Research & Development | 0 | 2.53M | 3.18M | 588.21K | 3.84M | 3.85M | 507.42K | 1.67M | 2.4M |
| R&D % of Revenue | - | - | - | 3.12% | 1.94% | - | 0.4% | 0.54% | 0.79% |
| Other Operating Expenses | 0 | 0 | 0 | 254.41K | 359.2K | -437.15K | 4.39M | 776.5K | 611.04K |
| Operating Income | -173K | -4.6M | -5.83M | -2.86M | -5.57M | -8.34M | -12.6M | -10.28M | -10.64M |
| Operating Margin % | - | - | - | -15.14% | -2.81% | - | -10.02% | -3.3% | -3.49% |
| Operating Income Growth % | - | -25.61% | -0.27% | 0.51% | -0.95% | -0.5% | -0.51% | 0.18% | -0.04% |
| EBITDA | 15.72K | 0 | 0 | -254.41K | -359.2K | -8.33M | -11.63M | -9.31M | -9.67M |
| EBITDA Margin % | - | - | - | -1.35% | -0.18% | - | -9.25% | -2.99% | -3.17% |
| EBITDA Growth % | - | -1% | - | - | -0.41% | -22.18% | -0.4% | 0.2% | -0.04% |
| D&A (Non-Cash Add-back) | 188.72K | 4.6M | 5.83M | 2.6M | 5.21M | 0 | 966.73K | 974.36K | 970.12K |
| EBIT | -173K | -4.6M | -6.73M | -2.6M | -5.21M | -8.33M | -10.44M | -10.28M | -10.42M |
| Net Interest Income | 0 | -453K | -665K | -458K | -1.08M | 6.89K | -214K | -82.32K | 40.63K |
| Interest Income | 151.28K | 0 | 188 | 97 | 13.81K | 14.43K | 9.68K | 84.82K | 101.52K |
| Interest Expense | 0 | 453.87K | 664.84K | 457.75K | 1.09M | 7.54K | 223.53K | 167.14K | 60.89K |
| Other Income/Expense | -139K | -453K | -1.56M | -335.96K | -1.49M | 2.9K | 1.93M | 92.24K | 39.72K |
| Pretax Income | -312K | -5.06M | -7.39M | -3.19M | -7.06M | -8.33M | -10.66M | -10.19M | -10.6M |
| Pretax Margin % | - | - | - | -16.92% | -3.56% | - | -8.48% | -3.27% | -3.47% |
| Income Tax | 0 | -36.39K | -57.69K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1.09% | 0.99% | 0.99% | 0.99% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -340K | -5.02M | -7.34M | -3.16M | -7.04M | -8.31M | -10.63M | -10.16M | -10.57M |
| Net Margin % | - | - | - | -16.76% | -3.55% | - | -8.46% | -3.26% | -3.46% |
| Net Income Growth % | - | -13.76% | -0.46% | 0.57% | -1.22% | -0.18% | -0.28% | 0.04% | -0.04% |
| Net Income (Continuing) | -312K | -5.06M | -7.39M | -3.19M | -7.06M | -8.33M | -10.66M | -10.19M | -10.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 1.31M | 637.92K | -28.31K | -51.23K | -79.15K | -111.99K | -146.16K | -182.31K |
| EPS (Diluted) | -0.99 | -14.60 | -21.01 | -8.92 | -16.22 | -11.33 | -10.58 | -6.38 | -2.00 |
| EPS Growth % | - | -13.75% | -0.44% | 0.58% | -0.82% | 0.3% | 0.07% | 0.4% | 0.69% |
| EPS (Basic) | -0.99 | -14.60 | -21.01 | -8.92 | -16.22 | -11.33 | -10.58 | -6.38 | -2.00 |
| Diluted Shares Outstanding | 603.96K | 603.96K | 603.96K | 709.2K | 520.74K | 733.26K | 2.01M | 3.19M | 5.27M |
| Basic Shares Outstanding | 603.96K | 603.96K | 603.96K | 709.2K | 520.74K | 733.26K | 2.01M | 3.19M | 5.27M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 667.23K | 2.5M | 2.33M | 476.33K | 18.21M | 10.87M | 3.86M | 8.53M | 4.14M |
| Cash & Short-Term Investments | 56.03K | 418.42K | 197.94K | 427.27K | 12.57M | 8.28M | 1.54M | 6.3M | 1.02M |
| Cash Only | 56.03K | 418.42K | 197.94K | 427.27K | 12.57M | 8.24M | 1.54M | 6.3M | 1.02M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 46.6K | 0 | 0 | 0 |
| Accounts Receivable | 0 | 36.48K | 94.5K | 19.59K | 2.1M | 1.53M | 833.16K | 978.35K | 1.6M |
| Days Sales Outstanding | - | - | - | 37.89 | 386.82 | - | 241.95 | 114.76 | 191.21 |
| Inventory | 0 | 2.03M | 1.98M | 0 | 0 | 0 | 979.91K | 777.54K | 635.22K |
| Days Inventory Outstanding | - | - | - | - | - | - | 384.5 | 168.31 | 128.4 |
| Other Current Assets | 611.19K | 2M | 0 | 0 | 3.21M | 936.68K | 34.1K | 111.19K | 394.66K |
| Total Non-Current Assets | 611.19K | 1.98M | 1.98M | 2M | 3.65M | 1.48M | 6.49M | 5.24M | 4.11M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 391.41K | 1.24M | 872.59K | 320.85K |
| Fixed Asset Turnover | - | - | - | - | - | - | 1.02x | 3.57x | 9.51x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 5.26M | 4.37M | 3.79M |
| Long-Term Investments | 0 | 0 | 0 | 135.69K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 611.19K | 1.98M | 1.98M | 1.86M | 3.65M | 1.09M | 0 | 0 | 0 |
| Total Assets | 667.23K | 2.5M | 2.33M | 2.48M | 21.86M | 12.35M | 10.35M | 13.78M | 8.25M |
| Asset Turnover | - | - | - | 0.08x | 0.09x | - | 0.12x | 0.23x | 0.37x |
| Asset Growth % | - | 2.74% | -0.07% | 0.06% | 7.83% | -0.43% | -0.16% | 0.33% | -0.4% |
| Total Current Liabilities | 6.58M | 5.56M | 6.31M | 7.69M | 3.68M | 4.66M | 5.88M | 5.45M | 5.35M |
| Accounts Payable | 339.17K | 167.47K | 849.72K | 483.58K | 1.36M | 715.9K | 1.2M | 602.34K | 897.26K |
| Days Payables Outstanding | - | - | - | - | - | - | 469.38 | 130.39 | 181.37 |
| Short-Term Debt | 3.53M | 4.84M | 5.13M | 5.13M | 0 | 0 | 576.66K | 790.12K | 197.15K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K |
| Other Current Liabilities | 2.71M | 466.27K | 50.41K | 1.83M | 2.1M | 2.84M | 1.19M | 332.34K | 534.99K |
| Current Ratio | 0.10x | 0.45x | 0.37x | 0.06x | 4.94x | 2.33x | 0.66x | 1.57x | 0.77x |
| Quick Ratio | 0.10x | 0.08x | 0.05x | 0.06x | 4.94x | 2.33x | 0.49x | 1.42x | 0.65x |
| Cash Conversion Cycle | - | - | - | - | - | - | 157.07 | 152.68 | 138.24 |
| Total Non-Current Liabilities | 3.87M | 5.01M | 0 | 0 | 3.17M | 1.14M | 783.93K | 144.94K | 84.92K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 759.03K | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 356.17K | 81.32K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 3.17M | 1.14M | -331.26K | 63.62K | 84.92K |
| Total Liabilities | 6.58M | 5.56M | 6.31M | 7.69M | 6.85M | 5.81M | 6.67M | 5.6M | 5.44M |
| Total Debt | 3.53M | 4.84M | 5.13M | 5.13M | 0 | 0 | 1.92M | 1.15M | 281.81K |
| Net Debt | 3.48M | 4.42M | 4.93M | 4.71M | -12.57M | -8.24M | 378.05K | -5.16M | -738.1K |
| Debt / Equity | - | - | - | - | - | - | 0.52x | 0.14x | 0.10x |
| Debt / EBITDA | 224.77x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 221.21x | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -10.14x | -8.78x | -6.24x | -5.09x | -1105.83x | -56.35x | -61.52x | -174.82x |
| Total Equity | -5.91M | -3.06M | -3.98M | -5.21M | 15.01M | 6.55M | 3.69M | 8.18M | 2.81M |
| Equity Growth % | - | 0.48% | -0.3% | -0.31% | 3.88% | -0.56% | -0.44% | 1.22% | -0.66% |
| Book Value per Share | -9.79 | -5.07 | -6.59 | -7.35 | 28.82 | 8.93 | 1.84 | 2.57 | 0.53 |
| Total Shareholders' Equity | -5.91M | -4.38M | -4.62M | -5.19M | 15.06M | 6.62M | 3.8M | 8.33M | 3M |
| Common Stock | 0 | 0 | 1.95M | 86.3K | 135.82K | 7.45K | 23.3K | 34.56K | 73.23K |
| Retained Earnings | -311.67K | -5.33M | -12.67M | -15.83M | -22.87M | -31.18M | -41.81M | -51.96M | -62.53M |
| Treasury Stock | 0 | 0 | -637.06K | 0 | 0 | 0 | -14 | -1 | -1 |
| Accumulated OCI | 2.72K | 571.11K | -216.87K | -363.95K | -661.26K | -788.13K | -575.5K | -712.61K | -327.94K |
| Minority Interest | 0 | 1.31M | 637.92K | -28.31K | -51.23K | -79.15K | -111.99K | -146.16K | -182.31K |
| Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -243.89K | -5.38M | -5.58M | -498.62K | -11.3M | -3.36M | -7.38M | -9.57M | -9.68M |
| Operating CF Margin % | - | - | - | -2.64% | -5.7% | - | -5.87% | -3.08% | -3.17% |
| Operating CF Growth % | - | -21.08% | -0.04% | 0.91% | -21.66% | 0.7% | -1.2% | -0.3% | -0.01% |
| Net Income | -311.67K | -5.06M | -7.39M | -3.19M | -7.06M | -8.33M | -10.66M | -10.19M | -10.6M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 966.73K | 1.21M | 1.21M |
| Stock-Based Compensation | 0 | 0 | 1.95M | 0 | 0 | 0 | 260K | 230.5K | 238.04K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -62.35K | -36.39K | 1.89M | 67.26K | 704.36K | 2.54M | 1.98M | -122.29K | 196.56K |
| Working Capital Changes | 65.07K | -327.88K | -132.81K | 2.63M | -4.94M | 2.44M | 78.92K | -701.93K | -720.78K |
| Change in Receivables | 0 | 0 | 0 | 118.06K | -1.03M | 2.5M | 591.79K | -13.81K | -2.86M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | -345.39K | 202.37K | 142.32K |
| Change in Payables | 65.07K | -327.88K | -132.81K | 2.41M | -973K | 242.66K | 84.5K | -632.95K | 0 |
| Cash from Investing | 0 | 0 | 0 | -14K | 0 | -880.22K | -694.14K | -221.43K | -231.84K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -380.22K | -505.12K | -221.43K | -231.84K |
| CapEx % of Revenue | - | - | - | - | - | - | 0.4% | 0.07% | 0.08% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 299.92K | 5.18M | 5.32M | 733.86K | 23.4M | 0 | 1.44M | 14.56M | 4.6M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | -3.38M | 3.75M | 5.32M | -116.4K | -1.49M | 0 | -1.34M | 1.66M | 7.94K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -243.89K | -5.38M | -5.58M | -498.62K | -11.3M | -3.74M | -7.88M | -9.79M | -9.91M |
| FCF Margin % | - | - | - | -2.64% | -5.7% | - | -6.27% | -3.15% | -3.25% |
| FCF Growth % | - | -21.08% | -0.04% | 0.91% | -21.66% | 0.67% | -1.11% | -0.24% | -0.01% |
| FCF per Share | -0.40 | -8.92 | -9.23 | -0.70 | -21.69 | -5.10 | -3.92 | -3.07 | -1.88 |
| FCF Conversion (FCF/Net Income) | 0.72x | 1.07x | 0.76x | 0.16x | 1.61x | 0.40x | 0.69x | 0.94x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 327.31K | 185.3K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | -143.74% | -77.08% | -207.8% | -171.13% | -192.21% |
| Return on Invested Capital (ROIC) | - | -254.25% | -378.16% | -956.85% | -434.4% | -1688.98% | -796.32% | -217.54% | -313.01% |
| Gross Margin | - | - | - | 100% | 100% | - | 25.99% | 45.81% | 40.85% |
| Net Margin | - | - | - | -1676.23% | -355.33% | - | -845.89% | -326.4% | -346.23% |
| Debt / Equity | - | - | - | - | - | - | 0.52x | 0.14x | 0.10x |
| Interest Coverage | - | -10.14x | -8.78x | -6.24x | -5.09x | -1105.83x | -56.35x | -61.52x | -174.82x |
| FCF Conversion | 0.72x | 1.07x | 0.76x | 0.16x | 1.61x | 0.40x | 0.69x | 0.94x | 0.92x |
| Revenue Growth | - | - | - | - | 949.3% | -100% | - | 147.58% | -1.9% |
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Other Sales | 196.71K | 623.48K | 578.64K |
| Other Sales Growth | - | 216.96% | -7.19% |
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Other Country | 189.19K | 470.56K | 132.7K |
| Other Country Growth | - | 148.72% | -71.80% |
| Asia Pacific | - | - | 41.58K |
| Asia Pacific Growth | - | - | - |
| Americas | - | - | 22.64K |
| Americas Growth | - | - | - |
| AUSTRALIA | 6.49K | 43.95K | - |
| AUSTRALIA Growth | - | 577.17% | - |
Intelligent Bio Solutions Inc. (INBS) reported $3.3M in revenue for fiscal year 2025.
Intelligent Bio Solutions Inc. (INBS) saw revenue decline by 1.9% over the past year.
Intelligent Bio Solutions Inc. (INBS) reported a net loss of $10.9M for fiscal year 2025.
Intelligent Bio Solutions Inc. (INBS) has a return on equity (ROE) of -192.2%. Negative ROE indicates the company is unprofitable.
Intelligent Bio Solutions Inc. (INBS) had negative free cash flow of $10.4M in fiscal year 2025, likely due to heavy capital investments.